Loading clinical trials...
Loading clinical trials...
A Phase I/IIa Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis
Conditions
Interventions
RS1 AAV Vector
Locations
1
United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Start Date
February 11, 2015
Primary Completion Date
April 25, 2024
Completion Date
October 16, 2024
Last Updated
February 14, 2025
NCT01306019
NCT07284641
NCT07174726
NCT06910358
NCT06139172
NCT06581146
Lead Sponsor
VegaVect, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions